View Post

UKIVAS Vasculitis Webinar

In News by John Geddes

The Second UKIVAS Online Educational Vasculitis Webinar for Medical Professionals Over two days, November 17th and 18th 2021, UKIVAS, the UK & Ireland Vasculitis Study Group, teamed up in partnership with the Royal …

View Post

New Research Study

In News by John Geddes

Would you like to help with a research study to better understand why some people with inflammatory conditions affecting the joints or the gut, and treated with immune suppressing medications …

View Post

Volunteers needed for trial

In News by John Geddes

Volunteers are needed for The PROTECT V Trial – Led by Addenbrookes Hospital  This new exciting trial, led by Dr Rona Smith at Addenbrookes, looks at how patients who are at particularly high risk …

View Post

Mirror interview for Hannah

In News by John Geddes

‘Wonder drug keeps me alive – but I may never be protected against Covid’ – Mirror Online Vasculitis patient Hannah Burden has secured valuable media coverage to help the public …

View Post

Covid – Third Jab

In News by John Geddes

The JCVI is advising that people with severely weakened immune systems should have a third vaccine dose as part of their primary COVID-19 vaccination schedule. The third dose, which is …

View Post

Third vaccine dose: trial

In News by John Geddes

A new clinical trial will investigate whether a third dose of vaccine for people with weakened immune systems gives a stronger immune response than two doses. The £2.2 million study …

View Post

OCTAVE study – initial findings

In News by John Geddes

OCTAVE study initial findings reveal vaccine responses in patients with impaired immune systems Published 24th August 2021 These findings are particularly concerning for those treated with rituximab with the highest proportion of …

View Post

Vasculitis: impact of Covid

In News by John Geddes

New research has found that people with rare autoimmune rheumatic diseases (including vasculitis) are at an increased risk of contracting COVID-19 and of COVID-19-related death. The findings demonstrate the urgent …